本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Caris Life Sciences, Inc.

28.21
-0.2900-1.02%
盤後28.210.00000.00%19:56 EDT
成交量:430.27萬
成交額:1.22億
市值:79.59億
市盈率:75.83
高:29.09
開:28.16
低:27.91
收:28.50
52周最高:34.54
52周最低:14.19
股本:2.82億
流通股本:1.16億
量比:1.07
換手率:3.71%
股息:- -
股息率:- -
每股收益(TTM):0.3720
每股收益(LYR):-3.2200
淨資產收益率:20.13%
總資產收益率:8.77%
市淨率:13.45
市盈率(LYR):-8.76

資料載入中...

2021/03/01

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/16

重要事件披露

8-K - Current report
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/04

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/03

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/03

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/02

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/29

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/12/31

重要事件披露

8-K - Current report
2020/12/29

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/11/30

重要事件披露

8-K - Current report
2020/11/06

重要事件披露

8-K - Current report
2020/11/02

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/10/29

重要事件披露

8-K - Current report
2020/09/14

重要事件披露

8-K - Current report
2020/08/17

重要事件披露

8-K - Current report
2020/08/07

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/06

重要事件披露

8-K - Current report